uPA/PAI-1, Oncotype DX™, MammaPrint®. Prognosis and predictive values for clinical utility in breast cancer management;uPA/PAI-1, Oncotype DX™, Mammaprint®. Valeurs pronostique et prédictive pour une utilité clinique dans la prise en charge du cancer du sein

Annales de Pathologie

Volumn 34, Issue 5, 2014, Pages 349-351

  Bellocq, Jean Pierre ^a   Luporsi, Élisabeth ^b   Barrière, JérÔme ^c   Bonastre, Julia ^d   Chetritt, JérÔme ^e   Le Corroller, Anne Gaëlle ^f   de Crémoux, Patricia ^g   Fina, Frédéric ^h   Gauchez, Anne Sophie ⁱ   Kassab Chahmi, Diana ^l   Lamy, Pierre Jean ^j   Martin, Pierre Marie ^d   Mazouni, Chafika ^d   Peyrat, Jean Philippe ^k   Romieu, Gilles ^j   Verdoni, Laetitia ^l   Mazeau Woynar, Valérie ^l  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Service d'anatomie pathologique Institut de cancérologie de Lorraine   (France)

^c CENTRE ANTOINE LACASSAGNE   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e Institut d'Histopathologie   (France)

^f INSERM   (France)

^g SAINT LOUIS HOSPITAL   (France)

^h ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j Service d'anatomie pathologique Institut régional du cancer   (France)

^k CENTRE OSCAR LAMBRET   (France)

^l INSTITUT NATIONAL DU CANCER   (France)

more..

Author keywords

Biomarkers; Breast cancer; Levels of evidence; Predictive value; Prognosis

Indexed keywords

ANTHRACYCLINE DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROTEIN HR; TUMOR MARKER; UNCLASSIFIED DRUG; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DNA MICROARRAY; HUMAN; LYMPH NODE; PATHOLOGY; PREDICTIVE VALUE; RECURRENCE FREE SURVIVAL; WEAKNESS; BLOOD; BREAST NEOPLASMS; CHEMISTRY; FEMALE; FRANCE; PROGNOSIS; REPRODUCIBILITY; TUMOR INVASION;

BREAST NEOPLASMS; FEMALE; FRANCE; HUMANS; LYMPH NODES; NEOPLASM INVASIVENESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84908285078     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annpat.2014.04.010     Document Type: Article

References (0)